ZIMBABWE’S medical aid societies are under intensifying pressure as government moves to separate insurers from service providers — a reform authorities say is critical to fixing structural distortions in private healthcare.
Information permanent secretary Ndabaningi Mangwana this week framed the issue bluntly: allowing to operate as both funders and providers has created a “serious conflict of interest” that threatens independent medical practice.
“We are coming up with a statutory instrument (SI) to stop medical aids societies from also providing services, as there is a serious conflict of interest threatening the existence of independent medical practice in Zimbabwe. Being the insurer and the provider has resulted in numerous challenges that we seek to correct,” Mangwana posted on X (formerly Twitter) on Thursday.
“Some medical aids are fighting this SI by hook and crook because they have been benefitting from the clear conflict of interest and anti-competitive nature of this arrangement.”
The proposed SI aims to dismantle that model, signalling a decisive policy shift away from vertically integrated healthcare financing.
For years, medical aid societies have defended rising premiums by citing escalating healthcare costs.
Keep Reading
- MMCZ moves to tackle chrome price crisis
- Bank charges eroding public confidence
- Ziyambi blames transport woes on sanctions
- Court fees up by 1 500%
But that argument is weakening.
Contributions have increased steadily, while tariffs have largely stagnated over the past decade.
At the same time, benefits have been reduced, leaving patients to absorb growing shortfalls.
The collapse of the National Tariff and Liaison Committee has further exposed systemic fault lines.
Once the central platform for negotiating tariffs between insurers and providers, it fell apart after medical aid societies withdrew.
Government now plans to revive it, marking a return to regulated pricing after years of unilateral tariff-setting by insurers.
At the core of the reforms is patient choice.
Medical aid societies have increasingly confined members to affiliated — often owned — facilities, creating a quasi-monopoly that limits competition and weakens quality.
The proposed changes seek to restore open access, allowing patients to choose providers based on trust and outcomes rather than financial constraints.
Healthcare providers argue the current structure enables systemic abuse.
Medical aid societies effectively control claims decisions, often rejecting referrals, delaying approvals or underpaying independent practitioners in ways that redirect patients to their own facilities.
Separating funding from service provision is intended to eliminate these incentives and rebalance the system.
Financial governance remains a critical concern.
Past scandals, including the Premier Service Medical Aid Society case, exposed how member contributions were diverted into non-core investments.
Critics warn that without reform, risk pools will continue to be misused.
Structural separation would ensure contributions are ring-fenced strictly for healthcare financing.
There are also clear economic implications.
While medical aid societies argue that owning facilities lowers costs, inefficiencies within those operations are often passed on through higher premiums.
Removing this burden could stabilise subscriptions and refocus insurers on their core mandate: risk pooling and claims management.
The reforms are also central to Zimbabwe’s long-term health strategy.
The planned National Health Insurance, aligned with Vision 2030 and the National Development Strategy 2 (NDS2), depends on a clear separation between purchaser and provider.
Without it, the system risks replicating the same inefficiencies now evident in medical aid societies.
Opponents argue medical aid societies-owned facilities provide affordable care, particularly for civil servants.
But repeated bailouts, drug shortages and service gaps suggest deeper structural problems.
Increasingly, the issue is seen not as infrastructure, but governance and liquidity.
The current model is also deterring investment.
Private players are reluctant to enter a market where insurers compete directly with providers while controlling patient access.
Reform, proponents argue, would level the field and unlock public-private partnerships.
The debate has shifted from whether reform is needed to how fast it can be implemented.
With rising costs, declining service quality and eroding trust, the status quo is no longer sustainable.
For government, separating medical aid societies from service provision is not incremental reform — it is a reset aimed at restoring transparency, competition and patient-centred care.